USE/OCC TX-EXEMPT PRESCRIPTION Senate SponsorsSen. Darby A. Hills 2/24/2026SenateAssigned to Revenue 35 ILCS 5/90135 ILCS 105/3-535 ILCS 105/3-10from Ch. 120, par. 439.33-1035 ILCS 110/3-535 ILCS 110/3-1035 ILCS 115/3-535 ILCS 115/3-1035 ILCS 120/2-535 ILCS 120/2-10from Ch. 120, par. 441-10Amends the Use Tax Act, the Service Use Tax Act, the Service Occupation Tax Act, and the Retailers' Occupation Tax Act. Provides that prescription medicines and products classified as Class III medical devices by the United States Food and Drug Administration that are used for cancer treatment pursuant to a prescription are exempt from the tax under the Acts. Amends the Illinois Income Tax Act. Increases the amount deposited into the Local Government Distributive Fund to: (i) 7.47% of the net revenue realized from the tax imposed upon individuals, trusts, estates, and pass-through entities; and (ii) 7.85% of the net revenue realized from the tax imposed upon corporations. Effective July 1, 2026. 2/6/2026SenateFiled with Secretary by Sen. John F. Curran 2/6/2026SenateFirst Reading 2/6/2026SenateReferred to Assignments 2/6/2026SenateAdded as Chief Co-Sponsor Sen. Darby A. Hills 2/24/2026SenateAssigned to Revenue 3/5/2026SenateChief Sponsor Changed to Sen. Darby A. Hills 3/13/2026SenateRule 2-10 Committee Deadline Established As April 24, 2026